Preclinical and Translational Immuno-Oncology
08
Aug
-
09
Aug
2023
When
Boston

USA
Where

Advances in harnessing the immune system for therapeutic development have resulted in a robust pipeline of immuno-oncology therapies and novel combinations. A successful program requires appropriate models and tools for preclinical evaluation and effective strategies for translation. Our expert speakers will discuss choosing the right preclinical model for assessing safety and efficacy, which models are best for recapitulating the tumor microenvironment, how to progress efficiently to clinical development, and the advantages of collaboration to drive innovation. Please join Cambridge Healthtech Institute’s 8th Annual Preclinical and Translational Immuno-Oncology meeting to explore innovative strategies to facilitate translation to the clinic.

Similar Events

You May Like

Event

Cambridge Healthtech Institute

0/5
(0)

Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.

08 - 09 Aug 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Postdoctoral Research Fellow
President & CEO
Postdoctoral Research Fellow
Assistant Professor
Associate Professor
Senior Scientist
Postdoctoral Researcher
Vice President, Preclinical Sciences
EVP Oncology
Senior Associate Producer
Associate Director

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Biocytogen

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.

FUJIFILM Pharmaceuticals U.S.A., Inc.

Our mission is to deliver innovative drugs to the broader population of patients worldwide at reasonable cost. FUJIFILM Pharmaceuticals U.S.A., Inc. started its operation in 2008 as FUJIFILM’s global center for new drug development.

Sanyou Biopharmaceuticals Co., Ltd.

Sanyou Biopharmaceuticals Co., Ltd. is a leading international biological high-tech enterprise focusing on R&D and services of innovative antibody drugs.

Genscript Probio

The CDMO segment of the world's leading biotech company GenScript.

Telesis Bio

Telesis Bio is empowering researchers to accelerate the creation of novel synthetic biology solutions to address some of humanity’s greatest challenges.

OmniAb, Inc.

The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

Selvita

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.

Nona Biosciences

Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal

BostonGene

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in

NeoSome Life Sciences

NeoSome Life Sciences is a PreClinical Research Organization providing in life modeling for several therapeutic research areas. We offer a range of services from Proof of Concept to IND enabling studies. Our specialties include Infectious Diseases, O

Organizer

Get emails from us

Thank you
Oops! Something went wrong